Return Home

about IAS-USA
news and events
cme programs
course registration
Cases on the Web
publications/guidelines
guidelines
Pocket Cards
Webcast and Podcasts
board and staff
core faculty
fdd
donations
contact
home


FACULTY

Elizabeth Connick, MD
Associate Professor of Medicine
University of Colorado Health Sciences Center
Denver, CO


Research Topics
  • Immunopathogenesis of HIV-1 infection
  • Lymphoid tissue immune responses in HIV-1 infection
  • Immune reconstitution in HIV-1 infection
  • Primary HIV-1 infection
  • Sex differences in HIV-1 infection


Lecture and Writing Topics
  • Immunopathogenesis of HIV-1 infection
  • Lymphoid tissue immune responses in HIV-1 infection
  • Immune reconstitution in HIV-1 infection
  • Primary HIV-1 infection


Current Professional Summary

Dr Connick is an Associate Professor of Medicine in the Division of Infectious Diseases at the University of Colorado Health Sciences Center. She performs translational research studies focusing on questions in HIV-1 immunopathogenesis and is currently the Principal Investigator of a program project grant to investigate the immunopathogenesis of acute and early HIV-1 infection. She is also involved in clinical trials research and has participated as a principal investigator as well as co-investigator in multiple AIDS Clinical Trials Group studies. Currently she serves as Associate Director for the General Clinical Research Center at the University of Colorado. She also is the Interim Co-Principal Investigator of the Immunology Core of the University of Colorado Center for AIDS Research. In addition to her research activities, Dr Connick is involved in the clinical care of patients with HIV-1 infection as well as other infectious diseases, and participates in teaching medical students, residents, and infectious disease fellows at the University of Colorado Health Sciences Center.


Committees and Organizations

  • Coinvestigator, AIDS Clinical Trials Group, University of Colorado ACTU


Education
  • Bryn Mawr College, (Anthropology) magna cum laude, AB (1978)
  • Harvard Medical School, MD (1988)
  • Columbia Presbyterian Hospital, Department of Medicine, Internship and Residency (1988-1991)
  • University of Colorado Health Sciences Center, Division of Infectious Diseases, Clinical and Research Fellow in Medicine (1991-1994)


Selected Publications
  1. Connick E, Lederman MM, Kotzin BL, Spritzler J, Kuritzkes DR, St Clair M, Sevin AD, Fox L, Chiozzi MH, Leonard JM, Rousseau F, D'Arc Roe J, Martinez A, Kessler H, Landay A. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response. J Infect Dis. 2000;181:358-363.
  2. Connick E, Schlichtemeier RL, Purner MB, Schneider KM, Anderson DM, MaWhinney S, Campbell TB, Kuritzkes DR, Douglas JM Jr, Judson FN, Schooley RT. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion. J Infect Dis. 2001;184:1465-1469.
  3. Folkvord JM, Anderson DM, Arya J, MaWhinney S, Connick E. Microanatomic relationships between CD8+ cells and HIV-1-producing cells in human lymphoid tissue in vivo. J Acquir Immune Defic Syndr. 2003;32:469-476.
  4. Campbell TB, Schneider K, Wrin T, Petropoulos CJ, Connick E. Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma. J Virol. 2003;77:12105-12112.
  5. Connick E, Kane MA, White IE, Ryder J, Campbell TB. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy. Clin Infect Dis. 2004;39:1852-1855.
  6. Campbell TB, Staskus KA, Folkvord J, White IE, Neid J, Zhang XQ, Connick E. Persistence of Kaposi sarcoma-associated herpesvirus (KSHV)-infected cells in KSHV/HIV-1-coinfected subjects without KSHV-associated diseases. J Infect Dis. 2005;191:367-371.

Return to Top



© Copyright 2012. International Antiviral Society–USA. All rights reserved.
Use of this site is subject to the Visitor's Agreement and Privacy and Confidentiality Policy.
Please read them carefully.